EQS-News: Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division
EQS-News: Marinomed Biotech AG / Key word(s): Strategic Company
Decision/AGM/EGM
Marinomed Biotech AG: Extraordinary general meeting approves sale of
Carragelose division
19.12.2024 / 12:39 CET/CEST
The issuer is solely responsible for the content of this announcement.
══════════════════════════════════════════════════════════════════════════
Marinomed Biotech AG: Extraordinary general meeting approves sale of
Carragelose division
• Required majority of shareholders vote in favour of the sale of the
Carragelose!-->…